Respiratory Care Devices Market Projected to Reach $36.7B by 2031
Event summary
- The global respiratory care devices market is valued at $25.5 billion in 2026 and is projected to reach $36.7 billion by 2031, growing at a CAGR of 7.6%.
- COPD and asthma together affect more than half a billion people globally, driving sustained demand for long-term oxygen therapy, ventilation support, nebulization, and monitoring.
- North America leads the market, supported by high healthcare spending and an established home medical equipment sector.
- Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure and rising respiratory disease burden.
The big picture
The respiratory care devices market is expanding due to a heavy and growing disease burden, including COPD and asthma, as well as an aging population and rising sleep apnea diagnoses. The shift from hospital-based to home-based care, driven by portable and connected devices, is a significant trend. The market is moderately consolidated but fragmented across individual product categories, with large medical technology companies competing alongside specialists in PAP therapy, humidification, and sleep apnea management.
What we're watching
- Technological Advancements
- The pace at which non-invasive, connected, and portable respiratory care devices will continue to mature and become central to chronic disease management.
- Regulatory Dynamics
- How ongoing regulatory upgrades and AI-assisted monitoring capabilities will shape the competitive landscape.
- Market Penetration
- Whether the industry can address cost, reimbursement, and upkeep challenges to expand adoption in resource-constrained healthcare systems.
Related topics
